Abemaciclib,Anastrozole,Letrozole
Eli Lilly,Novartis
['monarch-3', 'breast', 'sacituzumab', 'able,(-kable),(-eable)']
great to be in paris for #esmo2022
fantastic first proffered paper session on metastatic breast cancer. takeaways: - interim os analysis in monarch-3 is favorable (though not yet significant due to alpha splitting). - sacituzumab conferred a median 3.2 month improvement in os 
Oncologist & researcher at Memorial Sloan Kettering Cancer Center. Working on optimizing lifestyle & metabolic health to improve cancer risk and outcomes.